The role of glycosylation in autoimmune disease

Autoimmunity

Volumn 27, Issue 4, 1998, Pages 239-253

  Delves, Peter J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Agalactosyl IgG; Autoimmune disease; Autoimmunity; Glycosylation; Glycosyltransferases; Oligosaccharide

Indexed keywords

BLOOD GROUP ANTIGEN; OLIGOSACCHARIDE;

ANTIGENICITY; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CELL ADHESION; GLYCOSYLATION; INFLAMMATION; REVIEW; XENOTRANSPLANTATION;

EID: 0031779788     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939808993836     Document Type: Review

References (84)

1. 2-integrins and their cellular ligands. Eur. J. Biochem., 245, 215-232.
2. Lawson, J. H. and Platt, J. L. (1996). Molecular barriers to xenotransplantation. Transplantation, 62, 303-310.
3. Ragupathi, G. (1996). Carbohydrate antigens as targets for active specific immunotherapy. Cancer Immunol. Immunother., 43, 152-157.
4. Kreppel, L. K., Blomberg, M. A. and Hart, G. W. (1997). Dynamic glycosylation of nuclear and cytosolic proteins - Cloning and characterization of a unique O-GIcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem., 272.9308-9315.
5. Chan, P. Y., Lawrence, M. B., Dustin, M. L., Ferguson, L. M., Golan, D. E. and Springer, T. A. (1991). Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2. J. Cell. Biol., 115, 245-55.
6. Terry, R. W., Kwee, L., Levine, J. F. and Labow, M. A. (1993). Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein. Proc. Natl. Acad. Sci. USA, 90, 5919-5923.
7. Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Ann. Rev. Med., 46, 223-34.
8. Natsuka, S. and Lowe, J. B. (1994). Enzymes involved in mammalian oligosaccharide biosynthesis. Curr. Opin. Struct. Biol., 4, 683-691.
9. Paulson, J. C. and Colley, K. J. (1989). Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J. Biol. Chem., 264, 17615-17618.
10. Baenziger, J. U. (1994). Protein-specific glycosyltransferases - how and why they do it!. FASEB J., 8, 1019-1025.
11. Sumar, N. (1996). Analytical Methods 2: Lectins. In: Isenberg, D. A., Rademacher, T. W. eds Abnormalities of IgG Glycosylation and Immunological Disorders, Chichester: John Wiley and Sons, 65-87.
12. Wang, Y. and Rook, G. A. W. (1996). Analytical Methods 3 Monoclonal antibodies In: Isenberg, D. A., Rademacher, T. W. eds Abnormalities of IgG Glycosylation and Immunological Disorders, Chichester: John Wiley and Sons, 89-99.
13. Jones, R. H., Rademacher, T. W. and Williams, P. J. (1996). Bias in murine IgG isotype immobilisation. Implications for IgG glycoform analysis ELISA procedures. J. Immunol. Methods. 197, 109-120.
14. Williams, P. J. (1996). Analytical Methods 1: Biochemical In: Isenberg D. A., Rademacher T. W. eds Abnormalities of IgG Glycosylation and Immunological Disorders, Chichester: John Wiley and Sons., 45-64.
15. Tarentino, A. L. and Plummer, T. H. (1994). Enzymatic deglycosylation of asparagine-linked glycans - purification, properties, and specificity of oligosaccharide-cleaving enzymes from flavobacterium-meningosepticum. Methods Enzymol, 230, 44-57.
16. Stanley, P., Raju, T. S. and Bhaumik, M. (1996). CHO cells provide access to novel N-glycans and developmentally regulated glycosyltransferases. Glycobiology, 6, 695-699.
17. Zeng, G., Ariga, T., Gu, X. B. and Yu, R. K. (1995). Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation. Proc. Natl. Acad. Sci. USA, 92, 8670-8674.
18. Prieto, P. A., Mukerji, P., Kelder, B., Erney, R., Gonzalez, D., Yun, J. S., et al. (1995). Remodeling of mouse milk glycoconjugates by transgenic expression of a human glycosyltransferase J. Biol. Chem., 270, 29515-29519.
19. Asano, M., Furukawa, K., Kido, M., Matsumoto, S., Umesaki, Y., Kochibe, N. and Iwakura, Y. (1997). Growth retardation and early death of β-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J., 16, 1850-1857.
20. Lu, O., Hasty, P. and Shur, B. D. (1997). Targeted mutation in β1,4-galactosyltransferase leads to pituitary insufficiency and neonatal lethality. Dev. Biol., 181, 257-267.
21. Miller, D. J., Gong, X. and Shur, B. D. (1993). Sperm require beta-N-acetylglucosaminidase to penetrate through the egg zona pellucida. Development, 118, 1279-1289.
22. Wormald, M. R., Rudd, P. M., Harvey, D. J., Chang, S. C., Scragg, I. G. and Dwek, R. A. (1997). Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry, 36, 1370-1380.
23. Jefferis, R. and Lund, J. (1997). Glycosylation of antibody molecules: structural and functional significance. Chem. Immunol., 65, 111-128.
24. Wright, A. and Morrison, S. L. (1997). Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol, 15, 26-32.
25. Garcia, K. C., Degano, M., Stanfield, R. L., Brunmark, A., Jackson, M. R., Peterson, P. A., et al. (1996). An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science, 274, 209-219.
26. Dietrich, J., Neisig, A., Hou, X., Wegener, A. M., Gajhede, M. and Geisler, C. (1996). Role of CD3 gamma in T cell receptor assembly. J. Cell. Biol., 132, 299-310.
27. Ishikawa, S., Kowal, C., Cole, B., Thomson, C. and Diamond, B. (1995). Replacement of N-glycosylation sites on the MHC class II E α chain. Effect on thymic selection and peripheral T cell activation. J. Immunol., 154, 5023-5029.
28. b subsets to serve as TCR ligands for allo-specific CTL clones; potential role for N-linked glycosylation. J. Exp. Med., 181, 1773-1783.
29. Etzioni, A., Frydman, M., Pollack, S., Avidor, I., Phillips, M. L., Paulson, J. C. and Gershoni-Baruch, R. (1992). Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med., 327, 1789-1792.
30. Maly, P., Thall, A., Petryniak, B., Rogers, C. E., Smith, P. L., Marks, R. M., et al. (1996). The α(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-,E-, and P-selectin ligand biosynthesis. Cell, 86, 643-653.
31. Higgins, E. A., Siminovitch, K. A., Zhuang, D. L., Brockhausen, I. and Dennis, J. W. (1991). Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J. Biol Chem., 266, 6280-6290.
32. Piller, F., Le Deist, F., Weinberg, K. I., Parkman, R. and Fukuda, M. (1991). Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. J. Exp. Med., 173, 1501-1510.
33. Ellies, L. G., Tao, W., Fellinger, W., The, H. S. and Ziltener, H. J. (1996). The CD43 130-kD peripheral T-cell activation antigen is downregulated in thymic positive selection. Blood, 88, 1725-1732.
34. Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., et al. (1995). Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol., 131, 1623-1633.
35. Perillo, N. L., Pace, K. E., Seilhamer, J. J. and Baum, L. G. (1995). Apoptosis of T cells mediated by galectin-1. Nature, 378, 736-739.
36. Yang, R. Y., Hsu, D. K. and Liu, F. T. (1996). Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. USA., 93, 6737-6742.
37. Singhal, A. and Hakomori, S.-I. (1990). Molecular changes in carbohydrate antigens associated with cancer. BioEssays, 12, 223-230.
38. Mullinax, F. and Mullinax, G. L. (1975). Abnormality of IgG structure in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum, 18, 417-418.
39. Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., et al. (1985). Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature, 316, 452-457.
40. Tomana, M., Schrohenloher, R. E., Koopman, W. J., Alarcon, G. S. and Paul, W. A. (1988). Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum, 31, 333-338.
41. Tsuchiya, N., Endo, T., Matsuta, K., Yoshinoya, S., Takeuchi, F., Nagano, Y., et al. (1993). Detection of glycosylation abnormality in rheumatoid IgG using N-acetylglucosamine-specific Psathyrella velutina lectin. J. Immunol., 151, 1137-1146.
42. van-Zeben, D., Hazes, J. M., Zwinderman, A. H., Vandenbroucke, J. P. and Breedveld, F. C. (1993). Factors predicting outcome of rheumatoid arthritis: results of a followup study. J. Rheumatol., 20, 1288-1296.
43. Bond, A., Alavi, A., Axford, J. S., Bourke, B. E., Bruckner, F. E., Kerr, M. A., Maxwell, J. D., Tweed, K. J., Weldon, M. J., Youinou, P. and Hay, F. C. (1997). A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine J. Autoimmun., 10, 77-85.
44. Bond, A., Cooke, A. and Hay, F. C. (1990). Glycosylation of IgG. immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur. J. Immunol., 20, 2229-2233.
45. Thompson, S. J., Hitsumoto, Y., Zhang, Y. W., Rook, G. A. and Elson, C. J. (1992). Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin. Exp. Immunol., 89, 434-438.
46. McCulloch, J., Zhang, Y. W., Dawson, M., Harkiss, G. D., Peterhans, E., Vogt, H. R., et al. (1995). Glycosylation of IgG during potentially arthritogenic lentiviral infections. Rheumatol. Int., 14, 243-248.
47. Williams, P. J. and Rademacher, T. W. (1996). Analysis of murine IgG isotype galactosylation in collagen-induced arthritis. Scand. J. Immunol., 44, 381-387.
48. Rademacher, T. W., Williams, P. and Dwek, R. A. (1994). Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA, 91, 6123-6127.
49. Tsuchiya, N., Endo, T., Matsuta, K., Yoshinoya, S., Aikawa, T., Kosuge, E., Takeuchi, F., Miyamoto, T. and Kobata, A. (1989). Effects of galactose depletion from oligosaccharide chains on immunoglobulin activities of human IgG. J. Rheumatol., 16, 285-290.
50. Lund, J., Takahashi, N., Pound, J. D., Goodall, M. and Jefferis, R. (1996). Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. J. Immunol., 157, 4963-4969.
51. Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A. and Sim, R. B. (1995). Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med., 1, 237-243.
52. Cuchacovich, M., Gatica, H., Grigg, D. M., Pizzo, S. V. and Gonzalez-Gronow, M. (1996). Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis. J. Rheumatol., 23, 44-51.
53. White, K. D., Cummings, R. D. and Waxman, F. J. (1997). Ig N-glycan orientation can influence interactions with the complement system. J. Immunol., 158, 426-435.
54. Adler, Y., Lamour, A., Jamin, C., Menez, J. F., LeCorre, R., Shoenfeld, Y. and Youinou, P. (1995). Impaired binding capacity of asialyl and agalactosyl IgG to Fc gamma receptors. Clin. Exp. Rheumatol., 13, 315-319.
55. Newkirk, M. M., Novick, J., Stevenson, M. M., Fournier, M. J. and Apostolakos, P. (1996) Differential clearance of glycoforms of IgG in normal and autoimmune-prone mice. Clin. Exp. Immunol., 106, 259-264.
56. Groenink, J., Spijker, J., van den Herik-Oudijk, I. E., Boeije, L., Rook, G., Aarden, L., et al. (1996). On the interaction between agalactosyl IgG and Fc gamma receptors. Eur. J. Immunol., 26, 1404-1407.
57. Soltys, A. J., Hay, F. C., Bond, A., Axford, J. S., Jones, M. G., Randen, I., Thompson, K. M. and Natvig, J. B. (1994). The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand. J. Immunol., 40, 135-143.
58. Corper, A. L., Sohi, M. K., Bonagura, V. R., Steinitz, M., Jefferis, R., Feinstein, A., Beale, D., Taussig, M. J. and Sutton, B. J. (1997). Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Struct. Biol., 4, 374-381.
59. Bodman-Smith, K., Sumar, N., Sinclair, H., Roitt, I., Isenberg, D. and Young, A. (1996). Agalactosyl IgG [Gal(o)] - an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis. Br. J. Rheumatol., 35, 1063-1066.
60. Bond, A., Kerr, M. A. and Hay, F. C. (1995). Distinct oligosaccharide content of rheumatoid arthritis-derived immune complexes. Arthritis Rheum., 38, 744-49.
61. Axford, J. S., Lydyard, P. M., Isenberg, D. A., MacKenzie, L., Hay, F. C. and Roitt, I. M. (1987). Reduced B-cell galactosyltransferase activity in rheumatoid-arthritis. Lancet., ii, 1486-1488.
62. Wilson, I. B., Platt, F. M., Isenberg, D. A. and Rademacher, T. W. (1993). Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis. J. Rheumatol., 20, 1282-1287.
63. Furukawa, K., Matsuta, K., Takeuchi, F., Kosuge, E., Miyamoto, T. and Kobata, A. (1990). Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int. Immunol., 2, 105-112.
64. Keusch, J., Lydyard, P. M., Isenberg, D. A. and Delves, P. J. (1995). β1,4-Galactosyltransferase activity in B cells detected using a simple ELISA-based assay. Glycobiology, 5, 365-370.
65. Kumpel, B. M., Rademacher, T. W., Rook, G. A., Williams, P. J. and Wilson, I. B. (1994). Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum. Antibodies Hybridomas, 5, 143-151.
66. Delves, P. J. and Kidd, V. J. (1996). The glycosyltransferase genes. In: Isenberg, D. A., Rademacher, T. W. eds Abnormalities of IgG Glycosylation and Immunological Disorders. Chichester: John Wiley and Sons. 171-199.
67. Uehara, K. and Muramatsu, T. (1997). Molecular cloning and characterization of β-1,4-galactosyltransferase expressed in mouse testis. Eur. J. Biochem, 244, 706-712.
68. Pilkington, C., Taylor, P. V., Silverman, E., Isenberg, D. A., Del Costello, A. M. and Rook, G. A. W. (1996). Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus. Rheumatol. International, 16, 89-94.
69. Allen, A. C., Harper, S. J. and Feehally, J. (1995). Galactosylation of N- and O-linked carbohydrate moieties of IgA 1 and IgG in IgA nephropathy. Clin. Exp. Immunol., 100, 470-474.
70. Allen, A. C., Topham, P. S., Harper, S. J. and Feehally, J. (1997). Leucocyte β1,3 galactosyltransferase activity in IgA nephropathy. Nephrol. Dial. Transplant., 12, 701-706.
71. Hiki, Y., Iwase, H., Kokubo, T., Horii, A., Tanaka, A., Nishikido, J., Hotta, K. and Kobayashi, Y. (1996). Association of asialo-galactosyl β1-3N-acetylgalactosamine on the hinge with a conformational instability of Jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy. J. Am. Soc. Nephrol., 7, 955-960.
72. Tomana, M., Matousovic, K., Julian, B. A., Radl, J., Konecny, K. and Mestecky, J. (1997). Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney. Int., 52, 509-516.
73. Hadley, A. G., Zupanska, B., Kumpel, B. M., Pilkington, C., Griffiths, H. L., Leader, K. A., et al. (1995). The glycosylation of red cell autoantibodies affects their functional activity in vitro. Br. J. Haematol., 91, 587-594.
74. Lefebvre, J. C., Giordanengo, V., Limouse, M., Doglio, A., Cucchiarini, M., Monpoux, F., et al. (1994). Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J. Exp. Med., 180, 1609-1617.
75. + individuals. Blood, 86, 2302-2311.
76. Rapoport, B., McLachlan, S. M., Kakinuma, A. and Chazenbalk, G. D. (1996). Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate. J. Clin. Endocrinol. Metab., 81, 2525-2533.
77. Seetharamaiah, G. S., Dallas, J. S., Patibandla, S. A., Thotakura, N. R. and Prabhakar, B. S. (1997). Requirement of glycosylation of the human thyrotropin receptor ectodomain for its reactivity with autoantibodies in patients' sera. J. Immunol., 158, 2798-2804.
78. Galili, U. (1989). Abnormal expression of α-galactosyl epitopes in man. A trigger for autoimmune processes? Lancet., 2, 358-361.
79. Winand, R. J., Devigne, J. W., Mourisse, M. and Galili, U. (1994). Specific stimulation of Graves' disease thyrocytes by the natural anti-gal antibody from normal and autologous serum. J. Immunol., 153, 1386-1395.
80. Roitt, I. M., Pujol-Borrell, R., Hanafusa, T., Delves, P. J., Bottazzo, G. F. and Kohn, L. D. (1984). Asialoagalactothyroglobulin binds to the surface of human thyroid cells at a site distinct from the 'microsomal' autoantigen. Clin. Exp. Immunol., 56, 129-134.
81. Hafer-Macko, C., Pang, M., Seilhamer, J. J. and Baum, L. G. (1996). Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis. Glycoconj. J., 13, 591-597.
82. Bodman, K. B., Hutchings, P. R., Jeddi, P. A., Delves, P. J., Rook, G. A., Sumar, N., et al. (1994). IgG glycosylation in autoimmune-prone strains of mice. Clin. Exp. Immunol., 95, 103-107.
83. Delves, P. J., Jeddi, P. A., Bodman, K., Sumar, N., Lund, T., Pouncey, L., et al. (1992). Genes and IgG glycosylation in autoimmune and non-autoimmune strains of mice. Ann. Rheum. Dis., 51, 1275-1276.
84. Mackiewicz, A., Schultz, D., Mathison, J., Ganapathi, M. and Kushner, I. (1989). Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines. Clin. Exp. Immunol., 75, 70-75.